Top Recent FDA Approvals
Recent FDA approvals include treatments for acute low back pain, postoperative nausea and vomiting, multiple myeloma, hemophilia B, and fibromyalgia pain.
Recent FDA approvals include treatments for acute low back pain, postoperative nausea and vomiting, multiple myeloma, hemophilia B, and fibromyalgia pain.
Findings observed in women with early-stage breast cancer who were taking an aromatase inhibitor and had a score of 3 or higher on BPI-WP item.
The 2022 CDC Clinical Practice Guideline is intended to help clinicians weigh the benefits and risks of opioids and alternative pain treatments for outpatients.
In survey, some patients report less pain, better physical and social functioning after using medical cannabis.
Investigators assessed the impact of SARS-Cov-2 infection on pressure-pain sensitivity, conditioned pain modulation, and exercise-induced hypoalgesia.
A team of investigators assessed outcomes following epidural steroid injections for pain relief in older adults with new episodes of back pain.
Researchers conducted a retrospective cohort study to assess the impact of an implantable pump on opioid consumption in patients with chronic noncancer pain.
A 17-year-old Black adolescent presents with a 1-day history of acute-onset abdominal pain, palpitations, and anemia. Can you make the diagnosis?
Acupuncture can be considered an optional adjunctive pain treatment for acute renal colic, according to investigators.
Pain and addiction specialists discuss the rise in workplace violence over opioid denials and how to improve communication and change patient expectations.